A new trading day began on Monday, with Adaptive Biotechnologies Corp (NASDAQ: ADPT) stock price up 7.62% from the previous day of trading, before settling in for the closing price of $6.30. ADPT’s price has ranged from $2.28 to $7.07 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 27.46% over the last five years. Meanwhile, its annual earnings per share averaged 28.53%. With a float of $142.73 million, this company’s outstanding shares have now reached $147.56 million.
The firm has a total of 709 workers. Let’s measure their productivity. In terms of profitability, gross margin is 53.84%, operating margin of -93.9%, and the pretax margin is -110.17%.
Adaptive Biotechnologies Corp (ADPT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Adaptive Biotechnologies Corp is 3.28%, while institutional ownership is 92.21%. The most recent insider transaction that took place on Nov 18 ’24, was worth 1,235. In this transaction Chief Financial Officer of this company sold 248 shares at a rate of $4.98, taking the stock ownership to the 154,330 shares. Before that another transaction happened on Aug 22 ’24, when Company’s SVP and General Counsel sold 26,922 for $4.50, making the entire transaction worth $121,079. This insider now owns 139,365 shares in total.
Adaptive Biotechnologies Corp (ADPT) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 28.53% per share during the next fiscal year.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Here are Adaptive Biotechnologies Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.93 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corp (ADPT)
Analysing the last 5-days average volume posted by the [Adaptive Biotechnologies Corp, ADPT], we can find that recorded value of 1.19 million was lower than the volume posted last year of 1.41 million. As of the previous 9 days, the stock’s Stochastic %D was 43.62%. Additionally, its Average True Range was 0.46.
During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 91.11%, which indicates a significant increase from 83.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.94% in the past 14 days, which was lower than the 81.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.39, while its 200-day Moving Average is $4.17. Now, the first resistance to watch is $7.00. This is followed by the second major resistance level at $7.23. The third major resistance level sits at $7.66. If the price goes on to break the first support level at $6.34, it is likely to go to the next support level at $5.91. Should the price break the second support level, the third support level stands at $5.68.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats
With a market capitalization of 1.02 billion, the company has a total of 147,579K Shares Outstanding. Currently, annual sales are 170,280 K while annual income is -225,250 K. The company’s previous quarter sales were 46,440 K while its latest quarter income was -32,070 K.
